| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 生物活性 | Tirzepatide TFA (LY3298176 TFA) is a dualglucose-dependent insulinotropic polypeptide (GIP)andglucagon-like peptide-1 (GLP-1) receptoragonist that is being developed for the treatment of type 2 diabetes[1]. |
| IC50& Target | Glucose-dependent insulinotropic polypeptide (GIP), GLP-1 receptor[1] |
| Clinical Trial | |
| 分子量 | 4927.47 |
| Formula | C227H349F3N48O70 |
| Sequence Shortening | Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQ-{diacid-gamma-Glu-(AEEA)2-Lys}-AFVQWLIAGGPSSGAPPPS-NH2 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com